发明名称 |
4-(4-Chlorophenylsulphonylcarbamoyl)benzoyl-L-valyl-L-proline-1-(RS)-(1-trifluoroacetyl-2-methylpropyl)amide for treating haemorrhage associated with acute non-lymphocytic leukaemia. |
摘要 |
<p>The invention includes a novel therapeutic agent comprising 4-(4-chlorophenylsulphonylcarbamoyl)benzoyl-L-valyl-L-proline 1(RS)-(1-trifluoroacetyl-2methylpropyl)amide for use in the prevention or treatment of haemorrhagic conditions associated with acute non-lymphocytic leukaemia or its therapy, the use of this peptide derivative in the manufacture of a medicament for the prevention or treatment of said haemorrhagic conditions, as well as a method of prevention or treatment of said haemorrhagic conditions, as well as a method of prevention or treatment of said haemorrhagic conditions using the peptide derivative.</p> |
申请公布号 |
EP0463811(A2) |
申请公布日期 |
1992.01.02 |
申请号 |
EP19910305608 |
申请日期 |
1991.06.20 |
申请人 |
IMPERIAL CHEMICAL INDUSTRIES PLC |
发明人 |
GLASS, MITCHELL |
分类号 |
A61K38/00;A61K38/05;A61P35/02 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|